Enanta Pharmaceuticals, Inc., , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that AbbVie's investigational direct-acting antiviral combination regimen with and without ribavirin for the treatment of genotype 1 hepatitis C virus infection has been ... (more)
http://www.freshnews.com/news/794150/breakthrough-therapy-designation-u-s-food-and-drug-administration-granted-investigation
http://www.freshnews.com/news/794150/breakthrough-therapy-designation-u-s-food-and-drug-administration-granted-investigation
No comments:
Post a Comment